Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.
about
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexesIntracellular targeting with engineered proteinsHepatitis C virus and vaccine developmentAssembly and release of infectious hepatitis C virus involving unusual organization of the secretory pathwayScavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density GradientsPreclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant PatientsRole of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes.Studying Hepatitis C Virus: Making the Best of a Bad VirusAmphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral EntryInfluenza vaccines based on virus-like particlesInhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.An in vitro model of hepatitis C virion productionHepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro.A new model to produce infectious hepatitis C virus without the replication requirement.Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy.NS2 is dispensable for efficient assembly of hepatitis C virus-like particles in a bipartite trans-encapsidation system.Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivityMonoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system.Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in Escherichia coli.Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: binding and entry.Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantationMechanisms of hepatitis C virus infection.Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the VirusNeutralizing antibodies in hepatitis C virus infection.MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cellsNew therapeutic opportunities for hepatitis C based on small RNA.Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies.The role of HCV e2 protein glycosylation in functioning of virus envelope proteins in insect and Mammalian cells.High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes.Mouse monoclonal antibody towards e1 specific epitope blocks viral entry and intracellular viral replication in vitro.Evidence for cellular uptake of recombinant hepatitis C virus non-enveloped capsid-like particles.Mitogen-activated protein kinase signalling pathways triggered by the hepatitis C virus envelope protein E2: implications for the prevention of infection.Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry.Improved attachment of natural HCV isolate to Daudi cells upon elimination of immune complexes and close pH control.
P2860
Q24673768-32E799A8-7B0F-47AD-9605-D35146F8B923Q26740106-DCA924A4-527C-4CA8-A8EB-877B5202B79FQ27001610-04CF0D85-45B7-4552-808D-2DDD8D1D449BQ27468952-58D20161-CB11-4296-ACE3-6F0FEC0BEB27Q27469468-143816D0-359C-42F1-8734-491E120022A9Q27473044-D86EC9D7-8E2B-45A5-A8B1-A215E62EC06AQ27473046-FE9E14C7-2D79-4C46-B231-74658F413D80Q27473066-7564F7A7-44A1-4C39-B452-AFB2E052CB1BQ27481034-FDBC8E75-E609-47CF-8A1A-6502742276B9Q27490785-A49DFC9A-9464-42D6-818C-D869EFBF5997Q30376236-61BDA8DB-5306-460B-B73A-4AEA9D77A5FEQ30767073-9E6ED52A-4879-4AB9-8C85-AE27D258C9D0Q33850594-63D6EC06-6AC9-4F05-A9F4-AD7ABFEEDB24Q33867009-88793395-15D8-459F-8E49-50DDD4F44029Q33886707-4565D688-1394-49F3-A61D-724D9E79BB0AQ34016463-7E4102B1-0C5F-4A8E-B73E-BD1F731AF75EQ34366406-881D0B30-8751-4295-93E7-4EB87E8F0BD0Q34437763-C5D5C5F5-E82C-45DB-9EED-19D12BD07638Q34558519-9F5BC3B6-7F60-4308-9AC4-B7E709C815BAQ34605727-BBEC1369-466D-4EFA-BE3F-138D9EFE61DAQ34992715-365808C0-3B63-4F4B-939B-E525F04B7061Q35059730-7C7473A8-8A5B-452C-9631-1B64D481BBBAQ35231331-6EC962FE-DC13-4705-9353-80DF41A02DA3Q35621603-616886C9-7872-4210-B878-70ADD185A3DDQ35669529-51F95864-1697-483A-9D16-BB09CB660B20Q35821487-00FD8FD0-5EF5-4B76-99E7-983F0BAE1C56Q36179699-8316B6FD-B698-4CAC-B7CB-8F9F8B95ABF2Q36759971-AD2C2AF7-E950-4CEA-AD46-24D2B479C5C8Q36921336-AA5EDE04-9D57-4A99-AC7F-6DFF1A35AB3FQ36933791-01ACC998-5A4F-4954-A5AC-AFCDC3D1E2D1Q37834097-CFB4F628-81E8-40B4-A091-CA640FFD47C7Q38299373-E6814664-C430-4012-B9B4-AA823E712817Q38332447-407C00EB-F1C5-479B-9498-B52D486958A2Q38352468-FDA49478-08BE-4965-9914-D9E1CB1A9462Q38843888-CD2ABD47-8298-4A02-8737-AC8AEFA92F88Q39092405-496592AF-442F-4B59-9FA7-BA83E04B5572Q40097907-3FA0E99D-25F6-4ACB-9947-EE977E5C4101Q40106501-A8CC37B6-E3AA-4A30-B518-47D1C16378D2Q40150500-197C21C1-5ADC-4357-98B0-982E68B67FB3Q40409464-CE52FA99-FA47-42E2-A8CC-74F32CF8B147
P2860
Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Interaction of Hepatitis C Vir ...... udying Viral Binding and Entry
@nl
Interaction of hepatitis C vir ...... dying viral binding and entry.
@ast
Interaction of hepatitis C vir ...... dying viral binding and entry.
@en
type
label
Interaction of Hepatitis C Vir ...... udying Viral Binding and Entry
@nl
Interaction of hepatitis C vir ...... dying viral binding and entry.
@ast
Interaction of hepatitis C vir ...... dying viral binding and entry.
@en
prefLabel
Interaction of Hepatitis C Vir ...... udying Viral Binding and Entry
@nl
Interaction of hepatitis C vir ...... dying viral binding and entry.
@ast
Interaction of hepatitis C vir ...... dying viral binding and entry.
@en
P2093
P2860
P3181
P1433
P1476
Interaction of hepatitis C vir ...... dying viral binding and entry.
@en
P2093
Anthony R Davis
Arvind Patel
Bertrand Saunier
Leonard D Kohn
Luca Ulianich
Miriam Triyatni
Padma Maruvada
T Jake Liang
Theo Heller
P2860
P304
P3181
P356
10.1128/JVI.76.18.9335-9344.2002
P577
2002-09-01T00:00:00Z